{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-043801","form_type":"8-K","ticker":"AVR","cik":"0002011514","company_name":"Anteris Technologies Global Corp.","filed_at":"2025-12-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.306298+00:00","generated_at":"2026-05-16T15:56:42.864986+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"medium","headline":"Anteris Technologies not renewing supply agreement with 4C Medical for ADAPT tissue","bullets":["On Nov 26, 2025, Anteris notified 4C Medical of non-renewal of Second Amended Supply and License Agreement.","Agreement supplied ADAPT tissue for 4C's transcatheter mitral/tricuspid valve devices; term would expire June 1, 2026.","No early termination penalties incurred; company states termination does not materially impact financial results."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-043801","json":"https://secwatch.observer/filing/0001140361-25-043801.json","markdown":"https://secwatch.observer/filing/0001140361-25-043801.md","text":"https://secwatch.observer/filing/0001140361-25-043801.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2011514/000114036125043801/0001140361-25-043801-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2011514/000114036125043801/ef20060235_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T15:56:42.864986+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"56bec20a58c4223efce68e005f6f55f01a3c4a35","claim":"Anteris Technologies Global Corp. terminated Second Amended and Restated Supply and License Agreement, as amended with 4C Medical Technologies, Inc. (effective 2025-11-26).","evidence_excerpt":"On November 26, 2025, Anteris Technologies Global Corp. (the “Company”) notified 4C Medical Technologies, Inc. (“4C”) that it was not renewing the Second Amended and Restated Supply and License Agreement, as amended (the “Supply Agreement”), between the Company and 4C, which provided for the supply by the Company to 4C of ADAPT ® tissue used in 4C’s production of medical devices related to transcatheter mitral valve and tricuspid valve regurgitation therapy and granted a limited license to the Company’s related sterilization methods in connection with use of ADAPT ® tissue by 4C in its production of medical devices.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2011514/000114036125043801/0001140361-25-043801-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"supply"},{"label":"Counterparty","value":"4C Medical Technologies, Inc."},{"label":"Effective","value":"2025-11-26"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}